Position in CHRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$29,048
-$498,208 QoQ
Shares Held
20,749
-93.3% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 145 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,595,633,334 across 322 Biotechnology names. CHRS ranks #315 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in CHRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,048 | 20,749 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $527,256 | 311,986 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $937,840 | 660,451 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $1,010,353 | 1,382,153 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,340,261 | 2,899,952 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,448,452 | 1,049,603 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $829,411 | 797,511 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,065,728 | 616,028 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,005,097 | 1,257,363 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,464,922 | 2,842,319 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $810,379 | 216,679 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,640,038 | 852,468 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,494,362 | 218,474 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,297,558 | 542,621 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,969,859 | 517,155 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,818,568 | 389,305 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,608,594 | 202,060 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,273,838 | 330,441 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,778,281 | 484,025 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,431,527 | 248,122 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,893,820 | 403,410 | Shares | Sole | 2021-05-17 | |
| 2020-03-31 | $5,732,894 | 353,446 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||